32P Validation of the Scottish Immunotherapy Prognostic Score (SIPS) in NSCLC patients treated with first-line pembrolizumab
| Autor: | Gomez-Randulfe Rodriguez, M.I., Phillips, I., Gomes, F., Mackean, M., Stares, M. |
|---|---|
| Zdroj: | In ESMO Open February 2024 9 Supplement 1 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|